Pfizer Investigational Site is a clinical research site located in Chattanooga, Tennessee, United States 37404.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Pfizer Investigational Site has participated in 16 clinical trials.
Therapeutic areas: Carcinoma, Hepatocellular, Coronary Disease, Coronary Arteriosclerosis.
Sponsors: Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Ligand Pharmaceuticals.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Pfizer Investigational Site has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Pfizer Investigational Site has 16 clinical trials on record. Their work covers Carcinoma, Hepatocellular, Coronary Disease, Coronary Arteriosclerosis.
Yes — Pfizer Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.